{
  "id": "d0f6736de1a7b1fe",
  "title": "Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action - Disc Medicine ( NASDAQ : IRON ) ",
  "description": "20260116T190000Z",
  "content": "",
  "source": "benzinga.com",
  "source_url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/01/49974571/disc-medicine-analyst-remains-confident-in-rare-disease-drug-despite-fda-acti",
  "published_at": "20260116T190000Z",
  "fetched_at": "2026-01-17T00:22:29.333379+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug",
    "ai"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/26/01/49974571/disc-medicine-analyst-remains-confident-in-rare-disease-drug-despite-fda-acti",
    "url_mobile": "",
    "title": "Disc Medicine Analyst Remains Confident In Rare Disease Drug Despite FDA Action - Disc Medicine ( NASDAQ : IRON ) ",
    "seendate": "20260116T190000Z",
    "socialimage": "https://cdn.benzinga.com/files/images/story/2026/01/16/lab--Medical-Hospital-Research-Laborator.jpeg?&fit=crop",
    "domain": "benzinga.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}